Literature DB >> 14671396

Breast cancer and the environment.

Annie J Sasco1.   

Abstract

The most recent estimate of the overall worldwide burden of cancer is that in the year 2000 more than 10 million new cancer cases occurred and approximately 6 million cancer deaths. Breast cancer accounts for about 1 in 10 cancers and is the most frequent cancer affecting women. Since 10% of all cancers in the world are breast cancer (only affecting half of the population as breast cancer almost exclusively concerns only women), it is being considered an epidemic. In terms of the absolute number of incident cases, breast cancer now ranks first not only in the industrialized world but also in the developing world. The worldwide mortality figure for the year 2000 was 370,000. However, there are marked geographical differences, with Africa and Asia currently having incidence rates some 10 times lower than those of North America and northern Europe. Studies of migrant populations have long indicated that the genetic background only plays a tiny, if any, role in these differences. Over time, clear increases have been seen in the global number of cases: from 572,000 in 1980 to 1,050,000 in 2000. This corresponds not only to a modest increase in incidence rates in countries with a long history of frequent breast cancer but also to marked increases in countries with previously low rates. The reasons for these increases are currently unexplained and a possible hypothesis relates to environmental factors. By contrast, in a number of countries in the western world mortality rates are stable, and, in the USA and the United Kingdom, even decreasing slightly. The aetiology of breast cancer has been the subject of hundreds of studies since the pioneering investigation of Lane Claypon in 1926. Risk factors belong to different domains: reproductive life, hormonal factors, diet, genetics (BRCA1, BRCA2) and exposure to radiation and selected chemicals. Yet, much breast cancer remains unexplained and new aetiological links must be sought such as occupational factors and exposure to pesticides and other endocrine disrupters. A recent international summit on breast cancer and the environment outlined the need for more research to be conducted into the effects of exposure in the vicinity of nuclear power plants or chemical landfill sites and, more generally, into contaminants in food, air, water and soil. This is particularly relevant in some parts of the world such as Africa. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671396     DOI: 10.1159/000074500

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  10 in total

1.  17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.

Authors:  Juliette A Aka; Mausumi Mazumdar; Chang-Qing Chen; Donald Poirier; Sheng-Xiang Lin
Journal:  Mol Endocrinol       Date:  2010-02-19

2.  DDE-induced changes in aromatase activity in endometrial stromal cells in culture.

Authors:  Alison C Holloway; Katie A Stys; Warren G Foster
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

Review 3.  Mammary cancer susceptibility: human genes and rodent models.

Authors:  Claude Szpirer; Josiane Szpirer
Journal:  Mamm Genome       Date:  2007-12-01       Impact factor: 2.957

4.  Photodynamic therapy for the treatment of induced mammary tumor in rats.

Authors:  Isabelle Ferreira; Juliana Ferreira; José Dirceu Vollet-Filho; Lilian T Moriyama; Vanderlei S Bagnato; Daisy Maria Favero Salvadori; Noeme S Rocha
Journal:  Lasers Med Sci       Date:  2012-05-08       Impact factor: 3.161

5.  The organochlorine o,p'-DDT plays a role in coactivator-mediated MAPK crosstalk in MCF-7 breast cancer cells.

Authors:  Melyssa R Bratton; Daniel E Frigo; H Chris Segar; Kenneth P Nephew; John A McLachlan; Thomas E Wiese; Matthew E Burow
Journal:  Environ Health Perspect       Date:  2012-05-18       Impact factor: 9.031

6.  17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.

Authors:  Juliette A Aka; Mouna Zerradi; François Houle; Jacques Huot; Sheng-Xiang Lin
Journal:  Breast Cancer Res       Date:  2012-06-12       Impact factor: 6.466

7.  Comparison of functional proteomic analyses of human breast cancer cell lines T47D and MCF7.

Authors:  Juliette Adjo Aka; Juliette Adjo Aka; Sheng-Xiang Lin
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

8.  Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells.

Authors:  Ahter D Sanlioglu; Ercument Dirice; Cigdem Aydin; Nuray Erin; Sadi Koksoy; Salih Sanlioglu
Journal:  BMC Cancer       Date:  2005-05-25       Impact factor: 4.430

9.  Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania.

Authors:  Amos Rodger Mwakigonja; Nyanda Elias Lushina; Ally Mwanga
Journal:  Infect Agent Cancer       Date:  2017-11-06       Impact factor: 2.965

10.  Relationship between Chinese medicine dietary patterns and the incidence of breast cancer in Chinese women in Hong Kong: a retrospective cross-sectional survey.

Authors:  Xiao Zheng; Jianping Chen; Ting Xie; Zhiyu Xia; Wings Tjing Yung Loo; Lixing Lao; JieShu You; Jie Yang; Kamchuen Tsui; Feizhi Mo; Fei Gao
Journal:  Chin Med       Date:  2017-06-29       Impact factor: 5.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.